Subscribe To
Replimune presents updated interim results from the artacus clinical trial of rp1 monotherapy in solid organ and hematopoietic cell transplant recipients with skin cancers during oral presentation at
RP1 as monotherapy showed clear anti-tumor activity with an overall response rate of nearly 35 percent in evaluable patients WOBURN, Mass., Nov. 03, 2...
November 3, 2023, 11:30 pm
Replimune presents updated interim results from the artacus clinical trial of rp1 monotherapy in solid organ and hematopoietic cell transplant recipients with skin cancers during oral presentation at
RP1 as monotherapy showed clear anti-tumor activity with an overall response rate of nearly 35 percent in evaluable patients WOBURN, Mass., Nov. 03, 2...
November 3, 2023, 11:30 pm
Replimune presents updated interim results from the artacus clinical trial of rp1 monotherapy in solid organ and hematopoietic cell transplant recipients with skin cancers during oral presentation at
RP1 as monotherapy showed clear anti-tumor activity with an overall response rate of nearly 35 percent in evaluable patients WOBURN, Mass., Nov. 03, 2...
November 3, 2023, 11:30 pm
Replimune presents updated interim results from the artacus clinical trial of rp1 monotherapy in solid organ and hematopoietic cell transplant recipients with skin cancers during oral presentation at
RP1 as monotherapy showed clear anti-tumor activity with an overall response rate of nearly 35 percent in evaluable patients WOBURN, Mass., Nov. 03, 2...
November 3, 2023, 11:30 pm
A deep dive into bitcoin forks and alternatives for 2023
The world of cryptocurrency has witnessed significant growth and innovation in recent years. Bitcoin, the pion...
November 3, 2023, 4:29 pm
Workhorse group reschedules third quarter 2023 earnings call to tuesday, november 14, 2023 at 8:00 a.m. et
CINCINNATI, Nov. 03, 2023 (GLOBE NEWSWIRE) — Workhorse Group Inc. (Nasdaq: WKHS) (“Workhorse” or “the Company”), an American technology comp...
November 3, 2023, 12:30 pm
Future of flight: 3 stocks in the aerial car market with huge potential
Despite the sell-offs in the broader indices like the S&P 500, the potential of aerial car stocks holds steady. These companies are ...
November 3, 2023, 7:23 am
Lexeo therapeutics announces pricing of initial public offering
NEW YORK, Nov. 02, 2023 (GLOBE NEWSWIRE) — Lexeo Therapeutics, Inc. (Nasdaq: LXEO), a clinical stage genetic medicine company dedicated to transform...
November 3, 2023, 1:51 am
Siren biotechnology awarded $4m in grant funding from the california institute for regenerative medicine (cirm)
SAN FRANCISCO, Nov. 01, 2023 (GLOBE NEWSWIRE) — Siren Biotechnology, a gene therapy company pioneering...
November 1, 2023, 4:46 pm
Cellectis to report third quarter 2023 financial results on november 6, 2023
NEW YORK, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS- NASDAQ: CLLS), a clinical-stage biotechnology compa...
November 1, 2023, 4:30 pm
Neweternallife ico (elt): pioneering the digital frontier
NewEternalLife ICO (ELT): pioneering the Digital Frontier NewEternalLife ICO presents a groundbreaking ...
November 1, 2023, 1:26 pm
Verve and lilly relationship expands to include verve’s in vivo gene editing programs targeting pcsk9 and angptl3
Lilly Purchases Product Rights to Verve’s Lead Cardiovascular Programs from Beam Therapeutics BOSTON, Oct. 31, 2023 (GLOBE NEWSWIRE) — Verve Thera...
October 31, 2023, 10:01 am
Ideal power to host third quarter 2023 results conference call on november 14, 2023 at 10:00 am eastern time
AUSTIN, TX / ACCESSWIRE / October 31, 2023 / Ideal Power Inc. ("Ideal Power," the "Company," "we," "us" or "our") (NASDAQ:IPWR), ...
October 31, 2023, 9:20 am
Meme fusion ico (mefu) is in spotlight. what does it offer?
MEME Fusion ICO (MEFU) Is In The Spotlight. What Does It Offer? MEME Fusion ICO is currently live, and it’s attracting investors’ attention. This ...
October 30, 2023, 2:59 pm
Allogene therapeutics announces participation in november investor conferences
SOUTH SAN FRANCISCO, Calif., Oct. 30, 2023 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company
October 30, 2023, 8:30 am
Cisco systems' bullish odyssey: pioneering the future of technological excellence
The significant revenue growth of the Secure, Agile Networks segment is one of the crucial contributions to the rise in Cisco's operating income margi...
October 27, 2023, 1:52 am
Tapco collaborates with cubic transportation systems to offer pioneering intersection detection technology
Cubic’s Gridsmart system provides industry-leading video detection to traffic agencies with real-time data GRIDSMART’s Bell Camera The Bell Camera...
October 25, 2023, 2:15 pm
Biostax announces finra approval for name and ticker symbol change, signals entry into global substance abuse commercial markets and pioneering hiv treatment
ORLANDO, Fla., Oct. 24, 2023 (GLOBE NEWSWIRE) — Biostax Corp (OTC Pink: BTAX), a leading public company specializing in healthcare solutions, today ...
October 24, 2023, 1:15 pm
Wincanton wins contract to manage jet2's pioneering retail logistics
Wincanton PLC (LSE:WIN, OTC:WNCNF) has won a contract to manage the transport of goods for airline Jet2 PLC's retail operations. In a new contract...
October 24, 2023, 6:54 am
Robinhood makes sports sponsorship debut with washington wizards deal
Robinhood, the financial services platform renowned for pioneering commission-free stock trading, has b...
October 23, 2023, 5:59 pm